TDOC250509P10000
- 2.98
- 0.000.00%
Teladoc Health Newsroom
A Quick Look at Today's Ratings for Teladoc Health(TDOC.US), With a Forecast Between $7.5 to $8
Teladoc Health Announces Employee Inducement Awards Under NYSE Rule 303A.08
Teladoc Health | 10-Q: Q1 2025 Earnings Report
Teladoc Health Is Maintained at Buy by Goldman Sachs
Express News | Goldman Sachs Maintains Buy on Teladoc Health, Lowers Price Target to $10
Teladoc Health Is Maintained at Hold by Stifel
Express News | Evercore ISI Group Maintains In-Line on Teladoc Health, Lowers Price Target to $7
Forecasting The Future: 8 Analyst Projections For Teladoc Health
Express News | Needham Reiterates Hold on Teladoc Healthto Hold
Teladoc Health Analyst Ratings
Express News | Teladoc Health Inc : Leerink Partners Cuts Target Price to $7.50 From $10.00
Earnings Call Summary | Teladoc Health(TDOC.US) Q1 2025 Earnings Conference
Stephens Initiates Teladoc Health(TDOC.US) With Hold Rating, Announces Target Price $8
William Blair Maintains Teladoc Health(TDOC.US) With Hold Rating
CORRECTION: Teladoc Health Q1 Adj. EPS $(0.19) Beats $(0.34) Estimate, Sales $629.40M Beat $619.29M Estimate
Teladoc Health Acquires UpLift for $30M
Teladoc Health in Charts: U.S. Integrated Care Member Count Jumps in Q1
Teladoc Health Stock Slides On Q1 Earnings As Company Cuts FY25 Guidance
Teladoc Health: Due to Uncertainty Regarding Implementation Dates and Scope of U.S. Import Tariffs or Retaliatory Tariffs by Other Countries, Guidance Doesn't Include Impact From New Tariff Actions in 2025 >TDOC
Teladoc Health: Outlook Provided Below Is Based on Current Market Conditions and Expectations and What We Know Today, and Includes Anticipated Contribution From the Acquisition of UpLift >TDOC